IP Library Granted Patent US 10,174,331
Granted Patent B2
US 10,174,331 · App. 13/889,162 · Granted Jan 8, 2019

Methods and compositions for nuclease-mediated targeted integration of transgenes

Inventors: Gregory J. Cost (Richmond, CA); Fyodor Urnov (Richmond, CA); W. Michael Ainley (Indianapolis, IN); Joseph F. Petolino (Indianapolis, IN); Jayakumar Pon Samuel (Indianapolis, IN); Steven R. Webb (Indianapolis, IN); Lakshmi Sastry-Dent (Indianapolis, IN)
Assignees: Sangamo Therapeutics, Inc.; Dow AgroSciences LLC
C12N15/8201C12N15/102C12N15/8209C12N15/8213C12N15/8216C12N15/8241C12N15/8247C12N15/8274C12N15/8278C12N15/8286C12N15/85C12N15/87C12N2800/80Y02A40/162
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,174,331
App. No.
13/889,162
Granted
Jan 8, 2019
Kind
B2
Abstract

Disclosed herein are methods and compositions for homology-independent targeted insertion of donor molecules into the genome of a cell.

Claims (11)

1. A method of integrating a transgene into an endogenous locus of a cell, the method comprising;

introducing one or more nucleases into the cell, the cell comprising a circular double-stranded plasmid donor, the double-stranded plasmid donor comprising: a transgene; and first and second sequences flanking the transgene, the first and second sequences flanking the transgene comprising paired target sites for one or more nucleases, the target sites flanking a spacer sequence, wherein at least one spacer sequence differs from the spacer sequence present in the genome of the cell, wherein the double-stranded plasmid does not comprise homology arms and further wherein the nucleases cleave the double-stranded plasmid in the sequences flanking the transgene and cleave the endogenous locus such that the transgene is integrated into the endogenous locus via homology-independent mechanisms.

2. The method of claim 1 , wherein the transgene is integrated in a forward orientation.

3. The method of claim 1 , wherein the transgene is integrated in a reverse orientation.

4. The method of claim 1 , wherein the same nucleases cleave the endogenous locus and the double-stranded plasmid.

5. The method of claim 1 , wherein different nucleases cleave the endogenous locus and the double-stranded plasmid.

6. The method of claim 1 , wherein the spacer sequences comprise at least 5 nucleotides.

7. The method of claim 1 , wherein the nucleases generate a deletion in the endogenous locus and the transgene is integrated into the deletion.

8. The method of claim 1 , wherein the cell is a eukaryotic cell.

9. The method of claim 8 , wherein the cell is a plant or mammalian cell.

10. The method of claim 9 , wherein the plant cell is a dicotyledonous or a monocotyledonous plant cell.

Assignments (4)
CHANGE OF NAME Recorded Oct 4, 2018
From: SANGAMO BIOSCIENCES, INC.
To: SANGAMO THERAPEUTICS, INC.
Reel/Frame 047196/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2014
From: COST, GREGORY J.; URNOV, FYODOR
To: SANGAMO BIOSCIENCES, INC.
Reel/Frame 032433/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2014
From: AINLEY, W. MICHAEL; PETOLINO, JOSEPH F.; SAMUEL, JAYAKUMAR P.; WEBB, STEVEN R.; SASTRY-DENT, LAKSHMI
To: DOW AGROSCIENCES LLC
Reel/Frame 032433/0889 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2014
From: AINLEY, W. MICHAEL; PETOLINO, JOSEPH F; SAMUEL, JAYAKUMAR P; WEBB, STEVEN R; SASTRY-DENT, LAKSHMI
To: DOW AGROSCIENCES LLC
Reel/Frame 032331/0286 →
Continuity (2)
Provisional Application 61643812 · May 7, 2012
Related Publication 20130326645A1 · Dec 5, 2013